AS
Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ·Healthcare·Biotechnology
$0.20
-17.57%
Mkt Cap $4.29M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | $4.26K | — | — | -$1.33 | — | — | — |
| Q4 2025 Nov 14, 2025 | — | $1.94K | — | — | -$1.60 | — | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | — | -$0.04 | — | — | — |
| Q2 2025 May 14, 2025 | — | — | — | — | -$0.42 | — | — | — |
| Q2 2025 Apr 7, 2025 | — | — | — | — | -$0.27 | — | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | — | -$0.02 | — | — | — |
| Q3 2024 Aug 16, 2024 | — | — | — | — | -$0.02 | — | — | — |
| Q2 2024 Jun 5, 2024 | — | — | — | — | -$0.07 | — | — | — |
| Q1 2024 Mar 11, 2024 | — | — | — | — | -$0.00 | — | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | — | -$0.00 | — | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | — | $0.01 | — | — | — |
| Q2 2023 May 11, 2023 | — | — | — | — | $0.02 | — | — | — |
| Q1 2023 Mar 21, 2023 | — | — | — | — | $0.02 | — | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | — | $0.01 | — | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | — | $0.00 | — | — | — |
| Q2 2022 May 16, 2022 | — | — | — | — | -$0.00 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.00 | — | — | — |